Accustem Sciences (ACUT) Total Debt (2021 - 2025)
Accustem Sciences (ACUT) posted quarterly Total Debt of $22546.0 for Q4 2025, down 10.35% year-over-year from $25148.0 in Q4 2024, and down 49.55% quarter-over-quarter from $44689.0 in Q3 2025.
Accustem Sciences (ACUT) Total Debt (2021 - 2025) Analysis & Trends
Accustem Sciences (ACUT) has reported Total Debt for 5 consecutive years, with $22546.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Debt fell 10.35% year-over-year to $22546.0; the TTM figure through Dec 2025 stood at $22546.0 (down 10.35% YoY), while the FY2025 annual figure was $22546.0, down 10.35% from the prior year.
- Total Debt eased to $22546.0 in Q4 2025 per ACUT's latest filing, from $44689.0 in the prior quarter.
- Across five years, Total Debt topped out at $409359.0 in Q2 2022 and bottomed at $22546.0 in Q4 2025.
- Historically, Total Debt has averaged $143391.5 across 5 years, with a median of $77458.0 in 2022.
- Annual changes were most pronounced in 2022 — Total Debt surged 30.36% — and 2023, when it plunged 77.62%.
- Accustem Sciences' Total Debt stood at $190838.0 in 2021, then soared by 30.36% to $248780.0 in 2022, then slumped by 77.62% to $55679.0 in 2023, then plunged by 54.83% to $25148.0 in 2024, then dropped by 10.35% to $22546.0 in 2025.
- Business Quant data shows ACUT's Total Debt at $22546.0 in Q4 2025, $44689.0 in Q3 2025, and $66435.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 9.34 Bn |
| 10 | Accustem Sciences | 2.57 Mn | 2.56 Mn | - | 62,641.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22,546.00 |
| Sep 30, 2025 | 44,689.00 |
| Jun 30, 2025 | 66,435.00 |
| Dec 31, 2024 | 25,148.00 |
| Sep 30, 2024 | 57,597.00 |
| Jun 30, 2024 | 81,217.00 |
| Dec 31, 2023 | 55,679.00 |
| Sep 30, 2023 | 112,752.00 |
| Jun 30, 2023 | 297,880.00 |
| Dec 31, 2022 | 248,780.00 |
| Sep 30, 2022 | 320,862.00 |
| Jun 30, 2022 | 409,359.00 |
| Mar 31, 2022 | 73,699.00 |
| Dec 31, 2021 | 190,838.00 |